- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Skin Diseases, Infectious"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Skin Diseases, Infectious" (163 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02262819 | Recruiting | Human Immunity Against Staphylococcus Aureus Skin Infection |
|
|
Interventional |
Not Applicable |
|
NIH |
|
|
300 | All | 2 Years to 65 Years (Child, Adult, Older Adult) | NCT02262819 | 140199 14-I-0199 |
October 10, 2014 | January 1, 2025 | January 1, 2025 | October 13, 2014 | January 15, 2019 |
|
|||
2 | NCT03372941 | Not yet recruiting | Hospital Avoidance Strategies for ABSSSI |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
120 | All | 18 Years and older (Adult, Older Adult) | NCT03372941 | 201709136 | November 1, 2018 | September 1, 2019 | December 1, 2019 | December 14, 2017 | October 3, 2018 | ||||
3 | NCT03131843 | Recruiting | Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
170 | All | 2 Months to 18 Years (Child, Adult) | NCT03131843 | 33391 | May 1, 2017 | December 2018 | December 2018 | April 27, 2017 | May 2, 2017 |
|
|||
4 | NCT03637400 | Not yet recruiting | Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
462 | All | 9 Years to 85 Years (Child, Adult, Older Adult) | NCT03637400 | 30284 | October 16, 2018 | April 1, 2022 | November 1, 2022 | August 20, 2018 | August 20, 2018 |
|
|||
5 | NCT03643952 | Recruiting | Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029) |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
20 | All | 1 Year to 17 Years (Child) | NCT03643952 | 3009-029 MK-3009-029 184155 |
December 6, 2018 | May 14, 2021 | May 14, 2021 | August 23, 2018 | January 31, 2019 |
|
|||
6 | NCT02814916 | Recruiting | Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
300 | All | 3 Months to 17 Years (Child) | NCT02814916 | DUR001-306 2014-005281-30 |
March 30, 2017 | January 25, 2019 | January 25, 2019 | June 28, 2016 | June 7, 2018 |
|
|||
7 | NCT02566928 | Recruiting | Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
278 | All | 7 Years to 70 Years (Child, Adult, Older Adult) | NCT02566928 | CER-1402-10800 | CAMP-2 | October 2015 | November 2018 | December 31, 2018 | October 2, 2015 | July 21, 2017 |
|
||
8 | NCT03178747 | Recruiting | Tzanck Smear With Methylene Blue Stain for Herpes |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
150 | All | 18 Years and older (Adult, Older Adult) | NCT03178747 | 674/59 | March 7, 2017 | December 7, 2017 | March 6, 2018 | June 7, 2017 | August 4, 2017 |
|
|||
9 | NCT03747497 | Recruiting | Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT03747497 | MRX4-201 | November 15, 2018 | May 30, 2019 | June 30, 2019 | November 20, 2018 | February 15, 2019 |
|
|||
10 | NCT02582177 | Not yet recruiting | Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
160 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02582177 | ACH-CND-03(05/15) | DaVinci | August 1, 2018 | January 1, 2019 | February 1, 2019 | October 21, 2015 | April 9, 2018 | |||
11 | NCT03487549 | Recruiting | Cantharidin and Occlusion in Verruca Epithelium |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
55 | All | 2 Years and older (Child, Adult, Older Adult) | NCT03487549 | VP-102-105 | COVE-1 | March 27, 2018 | May 3, 2019 | July 5, 2019 | April 4, 2018 | December 21, 2018 |
|
||
12 | NCT03059992 | Recruiting | Open-Label Study to Evaluate Efficacy and Safety of SCY-078 in Patients With Refractory or Intolerant Fungal Diseases |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
60 | All | 18 Years and older (Adult, Older Adult) | NCT03059992 | SCY-078-301 2017-000381-29 |
FURI | April 1, 2017 | September 2019 | December 2019 | February 23, 2017 | February 15, 2019 |
|
||
13 | NCT02629419 | Recruiting | CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
16 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02629419 | MB-70004 16-I-0002 |
CAMB | September 2016 | September 2019 | December 2019 | December 14, 2015 | January 8, 2019 |
|
||
14 | NCT03731169 | Recruiting | CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT03731169 | 15-9226 | January 10, 2018 | June 2019 | June 2019 | November 6, 2018 | November 6, 2018 |
|
|||
15 | NCT03717623 | Not yet recruiting | Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT03717623 | 2017.105 | POPULAR | March 2019 | June 30, 2020 | December 31, 2020 | October 24, 2018 | January 28, 2019 | |||
16 | NCT03578679 | Recruiting | Treatment of Pediculosis (Head Lice) in Senegal |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
450 | Female | 6 Years and older (Child, Adult, Older Adult) | NCT03578679 | SEN17/16 | IVERAZITH | July 11, 2018 | September 16, 2018 | December 30, 2018 | July 6, 2018 | August 8, 2018 |
|
||
17 | NCT01782131 | Recruiting | A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
600 | All | 13 Years and older (Child, Adult, Older Adult) | NCT01782131 | P06200 2011-003938-14 5592-069 |
September 25, 2013 | June 19, 2019 | September 16, 2019 | February 1, 2013 | November 26, 2018 |
|
|||
18 | NCT01386437 | Recruiting | Natural History of Individuals With Immune System Problems That Lead to Fungal Infections |
|
Observational |
|
NIH |
|
|
700 | All | Child, Adult, Older Adult | NCT01386437 | 110187 11-I-0187 |
June 30, 2011 | July 1, 2011 | February 8, 2019 |
|
|||||||
19 | NCT03846635 | Recruiting New |
Handheld Infrared Thermometer to Evaluate Cellulitis |
|
Observational |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT03846635 | 2019-4850 | HI-TEC | August 28, 2018 | August 27, 2019 | August 27, 2019 | February 19, 2019 | February 19, 2019 |
|
||||
20 | NCT03785834 | Recruiting | The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis |
|
|
Observational |
|
Other |
|
|
60 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT03785834 | 2018H0147 | May 25, 2018 | June 1, 2019 | June 1, 2019 | December 24, 2018 | December 24, 2018 |
|
||||
21 | NCT03556917 | Recruiting | The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy. |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
30 | Female | 20 Years to 40 Years (Adult) | NCT03556917 | 2.264.773 | June 14, 2018 | December 17, 2018 | February 4, 2019 | June 14, 2018 | October 5, 2018 |
|
|||
22 | NCT03474523 | Recruiting | Effectiveness of Diathermy-Radiofrecuency Compared With Cavitation in Cellulitis Treatment |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
40 | Female | 18 Years to 40 Years (Adult) | NCT03474523 | Fisioterapia Bahía | October 20, 2017 | May 22, 2018 | June 28, 2018 | March 22, 2018 | May 3, 2018 |
|
|||
23 | NCT03814343 | Recruiting New |
Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT03814343 | 799/2018 | amphotericin | January 15, 2019 | January 15, 2020 | June 15, 2020 | January 24, 2019 | January 29, 2019 |
|
||
24 | NCT03837431 | Not yet recruiting New |
Cutaneous Leishmaniasis Diagnostic Study |
|
|
Observational |
|
Other |
|
|
350 | All | 2 Years and older (Child, Adult, Older Adult) | NCT03837431 | 1219/18 | February 15, 2019 | February 1, 2020 | May 1, 2020 | February 12, 2019 | February 12, 2019 |
|
||||
25 | NCT03829917 | Not yet recruiting New |
Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
120 | All | 12 Years and older (Child, Adult, Older Adult) | NCT03829917 | AB-2018-02 | February 2019 | February 1, 2020 | July 31, 2020 | February 4, 2019 | February 4, 2019 | ||||
26 | NCT03816176 | Not yet recruiting New |
A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
30 | All | 1 Year to 17 Years (Child) | NCT03816176 | 9766-CL-0107 | February 2019 | August 2021 | August 2021 | January 25, 2019 | January 25, 2019 | ||||
27 | NCT03784248 | Not yet recruiting | Mediterranean Visceral Leishmaniasis With Leishmania Infantum |
|
|
Observational |
|
Other |
|
|
1400 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03784248 | 17-API-02 | AsymptoGen | January 15, 2019 | January 15, 2021 | August 15, 2022 | December 21, 2018 | December 21, 2018 |
|
|||
28 | NCT03762070 | Recruiting | Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru |
|
|
Observational |
|
U.S. Fed |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT03762070 | LRDD-PERU-02 | October 2, 2018 | March 2019 | April 2019 | December 3, 2018 | December 3, 2018 |
|
||||
29 | NCT03646981 | Not yet recruiting | Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa |
|
|
Observational |
|
Other |
|
|
1684 | All | 4 Years to 100 Years (Child, Adult, Older Adult) | NCT03646981 | P08002-VL-DX-EAFR | VL-DX-EAFR | November 2018 | July 2019 | December 2019 | August 24, 2018 | August 24, 2018 | ||||
30 | NCT03636659 | Recruiting | Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
140 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03636659 | CR179-17 CTRI/2018/04/013350 |
May 2, 2018 | March 2019 | March 2019 | August 17, 2018 | August 17, 2018 |
|
|||
31 | NCT03399955 | Recruiting | Short Course Regimens for Treatment of PKDL (Sudan) |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
110 | All | 6 Years to 60 Years (Child, Adult) | NCT03399955 | DNDi-MILT COMB-02-PKDL | May 9, 2018 | May 9, 2021 | May 1, 2022 | January 17, 2018 | July 19, 2018 |
|
|||
32 | NCT03349931 | Recruiting | Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis |
|
|
Observational |
|
Other |
|
|
420 | All | 18 Years and older (Adult, Older Adult) | NCT03349931 | K-170102 2017-A01518-45 |
MYCOGENIE | February 5, 2018 | April 2019 | April 2019 | November 22, 2017 | May 1, 2018 |
|
|||
33 | NCT03336372 | Recruiting | Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients |
|
|
Interventional |
Early Phase 1 |
|
Other / Industry |
|
|
10 | All | 18 Years and older (Adult, Older Adult) | NCT03336372 | IIS-Picato-1386 | December 20, 2017 | July 1, 2018 | December 15, 2018 | November 8, 2017 | January 26, 2018 |
|
|||
34 | NCT03303898 | Recruiting | ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE - |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 19 Years and older (Adult, Older Adult) | NCT03303898 | 17-AOI-04 | Asymptoleish | November 10, 2017 | November 10, 2017 | March 10, 2019 | October 6, 2017 | July 24, 2018 |
|
||
35 | NCT03292835 | Not yet recruiting | Complex Cutaneous Leishmaniasis Healing Study in Algeria |
|
|
Observational |
|
Other / Industry |
|
|
100 | All | up to 90 Years (Child, Adult, Older Adult) | NCT03292835 | ALG 17/003 | LeiClean | September 1, 2019 | March 30, 2020 | March 31, 2020 | September 26, 2017 | December 24, 2018 | ||||
36 | NCT03221075 | Recruiting | Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy |
|
|
Observational |
|
Other |
|
|
220 | All | Child, Adult, Older Adult | NCT03221075 | 17-024 | CLARITY | March 1, 2017 | June 1, 2020 | July 1, 2020 | July 18, 2017 | October 30, 2018 |
|
|||
37 | NCT03129646 | Recruiting | Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
576 | All | 4 Years to 50 Years (Child, Adult) | NCT03129646 | DNDi-MILT/PM-01-VL | January 24, 2018 | November 30, 2019 | November 30, 2019 | April 26, 2017 | January 15, 2019 |
|
|||
38 | NCT03073967 | Recruiting | Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT03073967 | AIC316-03-II-01 | PRIOH-1 | May 8, 2017 | August 2019 | October 2019 | March 8, 2017 | February 5, 2019 |
|
||
39 | NCT03023111 | Not yet recruiting | Miltefosine and GM-CSF in Cutaneous Leishmaniasis |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
300 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03023111 | Mil GM CL-2017 | March 2017 | March 2019 | September 2019 | January 18, 2017 | January 20, 2017 | ||||
40 | NCT03013673 | Recruiting | Predicting Visceral Leishmaniasis in HIV Infected Patients |
|
|
Observational |
|
Other |
|
|
1045 | All | 18 Years and older (Adult, Older Adult) | NCT03013673 | ITM0915 | PreLeisH | October 11, 2017 | October 2021 | December 2021 | January 6, 2017 | October 11, 2018 |
|
|||
41 | NCT03004092 | Recruiting | Novel Biomarkers for Invasive Aspergillosis |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
226 | All | 16 Years and older (Child, Adult, Older Adult) | NCT03004092 | S59863 | January 2017 | December 2019 | February 2020 | December 28, 2016 | May 3, 2018 |
|
|||
42 | NCT02912026 | Not yet recruiting | Radiolabelled IV and Oral Metabolism Study of F901318 |
|
|
Interventional |
Phase 1 |
|
Industry / Other |
|
|
10 | Male | 40 Years to 65 Years (Adult, Older Adult) | NCT02912026 | F901318-01-08-16 | ADME | May 2019 | July 2019 | July 2019 | September 23, 2016 | August 1, 2018 |
|
||
43 | NCT02841215 | Not yet recruiting | Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
130 | All | 18 Years and older (Adult, Older Adult) | NCT02841215 | P140939 | GALECRUSTED | March 2017 | March 2019 | March 2019 | July 22, 2016 | December 8, 2016 |
|
||
44 | NCT02656797 | Recruiting | Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
108 | All | 18 Years and older (Adult, Older Adult) | NCT02656797 | sor017715ctil | January 30, 2018 | January 2020 | January 2021 | January 15, 2016 | April 20, 2018 |
|
|||
45 | NCT02429505 | Recruiting | Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry |
|
|
Observational |
|
Industry |
|
|
25 | All | 12 Years and older (Child, Adult, Older Adult) | NCT02429505 | IMP 2127-4 | July 2015 | March 2020 | March 2021 | April 29, 2015 | March 7, 2018 |
|
||||
46 | NCT02427308 | Recruiting | Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry |
|
|
Observational |
|
Industry |
|
|
2 | Female | Child, Adult, Older Adult | NCT02427308 | IMP 2127-1 | July 2015 | March 2025 | March 2026 | April 28, 2015 | March 7, 2018 |
|
||||
47 | NCT02193022 | Recruiting | Miltefosine for Children With PKDL |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
80 | All | 730 Days to 6569 Days (Child) | NCT02193022 | PR-13045 | July 2014 | June 2019 | June 2019 | July 17, 2014 | November 27, 2018 |
|
|||
48 | NCT01878383 | Recruiting | Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture |
|
|
Observational |
|
Other |
|
|
12700 | Female | 19 Years and older (Adult, Older Adult) | NCT01878383 | DMID 11-0070 | January 2014 | September 2019 | September 2019 | June 14, 2013 | February 8, 2019 |
|
||||
49 | NCT01641796 | Available | Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis |
|
|
Expanded Access |
|
U.S. Fed | All | Child, Adult, Older Adult | NCT01641796 | S-12-13 S-12-13/M-10337 |
July 17, 2012 | August 15, 2018 |
|
||||||||||
50 | NCT01277796 | Available | Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis |
|
|
Expanded Access |
|
Other | All | 8 Years to 80 Years (Child, Adult, Older Adult) | NCT01277796 | 032-08 | HECT | January 17, 2011 | January 17, 2011 | ||||||||||
51 | NCT00508963 | Available | Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis |
|
|
Expanded Access |
|
Other | All | 18 Years and older (Adult, Older Adult) | NCT00508963 | UCSF Infectious Diseases | July 30, 2007 | December 15, 2014 |
|
||||||||||
52 | NCT00344188 | Recruiting | Diagnosis and Treatment of Leishmanial Infections |
|
Observational |
|
NIH | 200 | All | 2 Years to 80 Years (Child, Adult, Older Adult) | NCT00344188 | 010238 01-I-0238 |
August 22, 2001 | June 26, 2006 | February 4, 2019 |
|
|||||||||
53 | NCT03619746 | Recruiting | Point-of-Care Ultrasound Educational Initiative for Insect Bites |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
304 | All | 3 Months to 20 Years (Child, Adult) | NCT03619746 | 2018-9176 | USED4BUGBITE | August 10, 2018 | August 2020 | August 2020 | August 8, 2018 | September 17, 2018 |
|
||
54 | NCT03312946 | Recruiting | Effect of Vibro-oscillatory Therapy for Improvement of Body Contour and Appearance of Cellulite. |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
30 | Female | 18 Years to 60 Years (Adult) | NCT03312946 | Ibramedmodellata | October 13, 2017 | December 4, 2017 | February 4, 2018 | October 18, 2017 | October 18, 2017 |
|
|||
55 | NCT02715037 | Not yet recruiting | Microbiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis |
|
|
Observational |
|
Other |
|
|
350 | All | 15 Years to 40 Years (Child, Adult) | NCT02715037 | 52683 | June 2016 | May 2019 | December 2021 | March 22, 2016 | March 22, 2016 |
|
||||
56 | NCT03676686 | Not yet recruiting | Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
48 | All | 18 Years and older (Adult, Older Adult) | NCT03676686 | Nåva Foot Cream_1 | September 2018 | March 2019 | March 2019 | September 19, 2018 | September 20, 2018 | ||||
57 | NCT03320486 | Recruiting | Non-inferiority Trial of Dapaconazole Versus Ketoconazole |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
360 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03320486 | GDN 018/16 | November 1, 2017 | November 2019 | November 2019 | October 25, 2017 | January 16, 2019 |
|
|||
58 | NCT02882438 | Recruiting | Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
30 | All | 20 Years to 40 Years (Adult) | NCT02882438 | AlAzharGGATP | January 2016 | September 2019 | October 2019 | August 29, 2016 | November 14, 2018 |
|
|||
59 | NCT03280927 | Recruiting | Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
100 | All | 19 Years and older (Adult, Older Adult) | NCT03280927 | JBL_OM_IV | November 10, 2017 | August 31, 2019 | October 1, 2019 | September 13, 2017 | June 4, 2018 |
|
|||
60 | NCT03171584 | Not yet recruiting | Antifungal Drugs in Treatment of Onychomycosis |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
60 | All | 20 Years to 60 Years (Adult) | NCT03171584 | oncho | July 1, 2017 | June 1, 2019 | November 1, 2019 | May 31, 2017 | May 31, 2017 | ||||
61 | NCT03066336 | Recruiting | A Study to See if Low Level Laser Light Can Help to Treat Toenail Fungus |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
54 | All | 18 Years and older (Adult, Older Adult) | NCT03066336 | EC_LL_MYC_PS | April 10, 2017 | June 2018 | June 2018 | February 28, 2017 | January 18, 2018 |
|
|||
62 | NCT03022903 | Recruiting | Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
10 | Female | 19 Years to 70 Years (Adult, Older Adult) | NCT03022903 | F150128007 | September 2015 | September 2019 | September 2019 | January 18, 2017 | October 22, 2018 |
|
|||
63 | NCT02961634 | Not yet recruiting | Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
46 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02961634 | EN16-0467-01 | April 2017 | August 2017 | August 2017 | November 11, 2016 | March 31, 2017 | ||||
64 | NCT02812043 | Recruiting | Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Older Adult) | NCT02812043 | 391/2558(EC1) | August 2016 | August 2018 | August 2018 | June 23, 2016 | September 6, 2017 |
|
|||
65 | NCT02724384 | Recruiting | Evaluating the Safety, Tolerability and Preliminary Efficacy of Plasma in Improving the Appearance of Onychomycosis |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
75 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02724384 | OM-0030 | March 2016 | December 2018 | February 2019 | March 31, 2016 | September 14, 2017 |
|
|||
66 | NCT02644551 | Recruiting | The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
120 | All | 18 Years and older (Adult, Older Adult) | NCT02644551 | CELEXT07-01 | November 2016 | May 2018 | September 2018 | January 1, 2016 | April 26, 2017 |
|
|||
67 | NCT03471455 | Not yet recruiting | Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT03471455 | INT/IEC/2017/850 | ISORD | April 2018 | January 2019 | January 2019 | March 20, 2018 | May 1, 2018 | |||
68 | NCT02922686 | Not yet recruiting | Penicillin for the Emergency Department Outpatient Treatment of CELLulitis |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
414 | All | 16 Years and older (Child, Adult, Older Adult) | NCT02922686 | EudraCT Number: 2016-001528-69 HRB HRA Project ID |
PEDOCELL | December 2016 | December 2019 | December 2019 | October 4, 2016 | October 4, 2016 |
|
||
69 | NCT03827798 | Not yet recruiting New |
Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
90 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03827798 | CCFZ533H12201BC | February 14, 2019 | June 17, 2020 | April 28, 2021 | February 1, 2019 | February 15, 2019 | ||||
70 | NCT03827694 | Recruiting New |
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections |
|
|
Observational |
|
Other / NIH |
|
|
400 | All | 120 Days to 21 Years (Child, Adult) | NCT03827694 | Pro00094558 R01AI139032 |
DOMINIC | October 30, 2018 | December 31, 2022 | December 31, 2022 | February 1, 2019 | February 6, 2019 |
|
|||
71 | NCT03784313 | Not yet recruiting | Perforator Flaps for Axillary Hidradenitis Suppurativa |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
88 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03784313 | P170931J 2018-A01244-51 |
HS-PAX | February 2019 | July 2021 | January 2022 | December 21, 2018 | December 21, 2018 |
|
||
72 | NCT03713632 | Not yet recruiting | Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
471 | All | 18 Years and older (Adult, Older Adult) | NCT03713632 | CAIN457M2302 | SUNRISE | February 1, 2019 | June 18, 2021 | April 22, 2022 | October 22, 2018 | October 22, 2018 | |||
73 | NCT03713619 | Not yet recruiting | This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS). |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
471 | All | 18 Years and older (Adult, Older Adult) | NCT03713619 | CAIN457M2301 | SUNSHINE | February 1, 2019 | June 18, 2021 | April 22, 2022 | October 22, 2018 | October 22, 2018 | |||
74 | NCT03672292 | Recruiting | Study to Evaluate the Safety and Efficacy of the Combination Therapy of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
60 | All | 18 Years and older (Adult, Older Adult) | NCT03672292 | SCY-078-206 2018-002565-18 |
SCYNERGIA | January 22, 2019 | September 2020 | October 2020 | September 14, 2018 | February 15, 2019 |
|
||
75 | NCT03656081 | Not yet recruiting | Chronic Pulmonary Aspergillosis and Ambisome Aerosol With Itraconazole |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
224 | All | 18 Years and older (Adult, Older Adult) | NCT03656081 | CPAAARI | November 2018 | May 2021 | May 2023 | September 3, 2018 | September 3, 2018 | ||||
76 | NCT03643185 | Recruiting | Cytokine Profile of Allergic Bronchopulmonary Aspergillosis |
|
Observational |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT03643185 | 20180627 | December 2014 | December 2018 | April 2019 | August 22, 2018 | August 27, 2018 |
|
|||||
77 | NCT03628924 | Recruiting | A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
180 | All | 18 Years and older (Adult, Older Adult) | NCT03628924 | CR108500 2018-001176-38 CNTO1959HDS2001 |
NOVA | September 4, 2018 | August 10, 2020 | October 29, 2020 | August 14, 2018 | January 28, 2019 |
|
||
78 | NCT03607487 | Recruiting | A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
36 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03607487 | INCB 54707-203 | September 18, 2018 | November 2019 | May 2020 | July 31, 2018 | January 4, 2019 |
|
|||
79 | NCT03569371 | Recruiting | A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
10 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03569371 | INCB 54707-202 | June 11, 2018 | April 2019 | April 2019 | June 26, 2018 | December 6, 2018 |
|
|||
80 | NCT03512275 | Recruiting | A Study of Bermekimab in Patients With Hidradenitis Suppurativa |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT03512275 | 2018-PT045 | June 20, 2018 | December 2018 | December 2018 | April 30, 2018 | August 31, 2018 |
|
|||
81 | NCT03469232 | Recruiting | Effectiveness and Clinical Mechanism of Huanglian-Jiedu Decoction in Patients With Intense-exuberant Stomach Fire Syndrome |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
240 | All | 18 Years to 60 Years (Adult) | NCT03469232 | HLJD-V3 | April 4, 2018 | September 1, 2018 | November 1, 2018 | March 19, 2018 | April 10, 2018 |
|
|||
82 | NCT03443336 | Recruiting | Azole-resistance in Aspergillus |
|
Observational |
|
Other |
|
|
400 | All | Child, Adult, Older Adult | NCT03443336 | 2017-00984 | me17Khanna | June 1, 2017 | December 31, 2018 | December 31, 2019 | February 23, 2018 | March 1, 2018 |
|
||||
83 | NCT03327727 | Recruiting | VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT03327727 | VL2397-201 2017-003435-11 |
February 20, 2018 | December 31, 2019 | December 31, 2019 | October 31, 2017 | February 6, 2019 |
|
|||
84 | NCT03289585 | Recruiting | A National Registry For Patients With Hidradenitis Suppurativa |
|
Observational |
|
Other |
|
|
400 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT03289585 | 2014-3835 SRC | August 2015 | August 2020 | August 2020 | September 21, 2017 | February 7, 2019 |
|
|||||
85 | NCT03288337 | Recruiting | Impact of Hidradenitis Suppurativa on Quality of Life Functions |
|
Observational |
|
Other / Industry |
|
|
400 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT03288337 | 2014-3873 | April 2015 | August 2020 | August 2020 | September 20, 2017 | February 8, 2019 |
|
|||||
86 | NCT03275870 | Recruiting | Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT03275870 | PRO17030612 | September 28, 2017 | June 2019 | June 2019 | September 8, 2017 | October 19, 2018 |
|
|||
87 | NCT03267394 | Not yet recruiting | Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis |
|
Observational |
|
Other |
|
|
75 | All | Child, Adult, Older Adult | NCT03267394 | TARC in diagnosis of ABPA | October 2017 | October 2018 | November 2018 | August 30, 2017 | August 30, 2017 | ||||||
88 | NCT03265366 | Not yet recruiting | Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
27 | All | 18 Years and older (Adult, Older Adult) | NCT03265366 | CHUBX 2016/12 | ABPA-MR | September 2017 | September 2018 | September 2018 | August 29, 2017 | August 30, 2017 |
|
||
89 | NCT03221621 | Recruiting | Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
128 | All | 18 Years and older (Adult, Older Adult) | NCT03221621 | HS-COST | HS-COST | July 31, 2018 | July 31, 2022 | July 31, 2022 | July 18, 2017 | February 8, 2019 |
|
||
90 | NCT03217474 | Recruiting | Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
100 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03217474 | 2017KYPJ052 | July 20, 2017 | December 30, 2018 | December 30, 2019 | July 14, 2017 | February 22, 2018 |
|
|||
91 | NCT03203122 | Recruiting | Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
20 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03203122 | REG-115-2016 | August 7, 2017 | August 1, 2018 | August 1, 2019 | June 29, 2017 | June 29, 2017 |
|
|||
92 | NCT03199781 | Recruiting | Motorized Mechanical Massage Associated With Cosmetics in Improving Body Contour and Appearance of Gynoid Lipodystrophy |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
30 | Female | 18 Years to 50 Years (Adult) | NCT03199781 | Ibramed | May 30, 2017 | August 20, 2017 | September 15, 2017 | June 27, 2017 | June 27, 2017 |
|
|||
93 | NCT03146676 | Recruiting | The Ohio State University Dermatology Biorepository, Molecular Biology and Genetics of Hidradenitis Suppurativa |
|
Observational |
|
Other |
|
|
175 | All | Child, Adult, Older Adult | NCT03146676 | 2010H0331 | April 19, 2017 | January 2018 | January 2022 | May 10, 2017 | June 1, 2017 |
|
|||||
94 | NCT03121235 | Recruiting | PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. |
|
|
Observational |
|
Other / Industry |
|
|
280 | All | 18 Years and older (Adult, Older Adult) | NCT03121235 | MEC-2016-664 | AzorMan | April 20, 2017 | October 15, 2019 | October 15, 2019 | April 20, 2017 | March 22, 2018 |
|
|||
95 | NCT03099980 | Recruiting | Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
21 | All | 18 Years and older (Adult, Older Adult) | NCT03099980 | CAIN457AUS03T | July 11, 2016 | August 2018 | January 2019 | April 4, 2017 | March 15, 2018 |
|
|||
96 | NCT03084952 | Not yet recruiting | Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
52 | All | 18 Years to 59 Years (Adult) | NCT03084952 | HB/F2-002/2016 | November 2018 | March 2019 | November 2019 | March 21, 2017 | August 9, 2018 |
|
|||
97 | NCT03846648 | Not yet recruiting New |
CyPep-1 in Cutaneous Warts |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
58 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03846648 | CHDR1803 NL67664.056.18 |
March 11, 2019 | February 28, 2020 | February 28, 2020 | February 19, 2019 | February 19, 2019 | ||||
98 | NCT03830047 | Not yet recruiting New |
Effect of Laser in Treatment of Vulval Warts |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
40 | Female | 18 Years to 40 Years (Adult) | NCT03830047 | laser | February 7, 2019 | October 15, 2019 | November 20, 2019 | February 5, 2019 | February 5, 2019 |
|
|||
99 | NCT03828773 | Recruiting New |
PTX3-targeted Antifungal Prophylaxis |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
320 | All | 18 Years and older (Adult, Older Adult) | NCT03828773 | 2018-01671 | PTX3AML | February 11, 2019 | July 31, 2022 | July 31, 2022 | February 4, 2019 | February 15, 2019 |
|
||
100 | NCT03054155 | Recruiting | Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
20 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03054155 | 120116M1F | May 11, 2017 | October 31, 2019 | October 31, 2019 | February 15, 2017 | October 5, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.